Determining thedistribution of biologically active compounds within cells is a major issue to
understand their mechanism of action and to optimize their properties. Over the
past decade DNA secondary structures called G-quadruplexes (G4) have been
identified as key modulators of genomic functions. This very active research
field has led to the development of G4-targeted molecular probes that are used
to track quadruplex forming domains in cells, which is achieved, in most cases,
by conventional fluorescence microcopy. However, the intrinsic low resolution
of fluorescence microcopy as well as the necessity to tag the drugs with
fluorophores represent strong limitations. Here we present the use of secondary
ion mass spectroscopy imaging (nanoSIMS) for mapping within metaphase human
chromosomes the distribution of a bromo-bisquinolinium phenanthroline
derivative (Br- PhenDC3) used as G-quadruplex probe. In addition a statistical
approach to increase the accuracy and the spatial resolution of the nanoSIMS
imaging was implemented as a plug in for the image analysis software ImageJ. The
results demonstrate the presence of Br-PhenDC3both at terminal and interstitial
regions of chromosomes and constitute a demonstration of the effectiveness of
nanoSIMS imaging as an alternative method for accurate genome-wide mapping of
DNA interactive drugs.
Most anticancer chemotherapeutic agents used in the clinic as
frontline drugs act as nuclear DNA binders. These agents are considered to bind
more or less randomly on the polymeric structure of DNA, or at least in a
non-controllable manner thereby hitting both crucial target regions and
off-target regions. This uncontrollable distribution is assumed to be
responsible for the high cytotoxicity and the potential mutagenicity frequently
associated with DNA interactive drugs, two features often used as decisive
arguments to decrease research and development studies on this class of
compounds. Therefore, determining whether DNA drugs localize uniformly or show
preference for certain genomic regions has become a crucial issue for the
development of optimized DNA binding anticancer agents in the future.
Surprisingly this topic remains largely unexplored so far, essentially due to
the lack of genome-wide analytical methods. However this has been recently
challenged by the emergence of Chemical-Sequencing (Chem-Seq) methodologies
which propose to map the genomic distribution of drugs by identifying
drug-induced DNA damages or repair protein recruitment using chemical capture
and sequencing. Nevertheless, although powerful and highly promising, Chem-Seq
approaches are still technically challenging, highly expensive in the case of
whole-genome studies and require extreme caution in data analysis with
stringent bioinformatics procedures [5,6]. In addition, they provide indirect
read out and not direct visualization of drug DNA binding targets.
Consequently, there is a strong need for new complementary imaging methods for
identifying the distribution of DNA interactive drugs at the genomic level.
Although drugs can
be labelled with fluorescent tags (or be intrinsically fluorescent) routine
fluorescence microscopy provides resolution limited by light diffraction
thereby enabling only the detection of spots (foci) corresponding to the
presence of at least 20-40 fluorophores or more. This works fine for
immunostaining strategies, in which the fluorescent signal is amplified by
heavily labelled antibodies, but it is not applicable to the detection of small
molecules unless these are confined in sub compartments (e.g. nucleus,
mitochondria, lysosomes),which increases the density of fluorescent markers.
Moreover, the labelling of drugs represents an issue as most fluorophores
impact target recognition and may modify drug intracellular localization and
penetration. Although super resolution microscopies hold great potential for
chromosome and cellular imaging with high spatial resolution, they are far from
being routine imaging techniques and they are highly dependent on the specific
photophysics of the dyes.
No comments:
Post a Comment